 | • レポートコード：QYR2104Z4652 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、血小板＆血漿のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血小板、血漿）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・血小板＆血漿の市場動向 ・企業の競争状況、市場シェア ・血小板＆血漿の種類別市場規模（血小板、血漿） ・血小板＆血漿の用途別市場規模（病院、クリニック、外来手術センター、その他） ・血小板＆血漿の北米市場規模2016-2027（アメリカ、カナダ） ・血小板＆血漿のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・血小板＆血漿のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血小板＆血漿の中南米市場規模2016-2027（メキシコ、ブラジル） ・血小板＆血漿の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（America’s Blood Centers、American Red Cross、American Association of Blood Banks、Blood Centers of America、Brazilian Red Cross、Canadian Red Cross、European Blood Alliance、French Red Cross、German Red Cross、Indian Red Cross、Italian Red Cross、Red Cross Society of China、Saudi Red Crescent Authority、South African Red Cross Society） ・結論 |
Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cells in whole blood in suspension; this makes plasma the extracellular matrix of blood cells.
Platelets have no cell nucleus: they are fragments of cytoplasm that are derived from the megakaryocytes of the bone marrow, and then enter the circulation. Circulating unactivated platelets are biconvex discoid (lens-shaped) structures,2–3 µm in greatest diameter. Platelets are found only in mammals, whereas in other animals (e.g. birds, amphibians) thrombocytes circulate as intact mononuclear cells. Plasma makes up about 55% of the body’s total blood volume.It is the intravascular fluid part of extracellular fluid (all body fluid outside cells). It is mostly water (up to 95% by volume), and contains dissolved proteins (6–8%) (i.e.—serum albumins, globulins, and fibrinogen), glucose, clotting factors, electrolytes (Na+, Ca2+, Mg2+, HCO3−, Cl−, etc.), hormones, carbon dioxide (plasma being the main medium for excretory product transportation) and oxygen. Plasma also serves as the protein reserve of the human body. It plays a vital role in an intravascular osmotic effect that keeps electrolytes in balanced form and protects the body from infection and other blood disorders. Rising prevalence of chronic diseases such as haemophilia, thrombocytopenia, haemorrhage, liver diseases as well as other rare and infectious diseases will drive the global platelet and plasma market.
Market Analysis and Insights: Global Platelet and Plasma Market
The global Platelet and Plasma market size is projected to reach US$ 5699.9 million by 2026, from US$ 5159.3 million in 2019, at a CAGR of 1.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Platelet and Plasma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Platelet and Plasma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Platelet and Plasma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Platelet and Plasma market.
Global Platelet and Plasma Scope and Market Size
Platelet and Plasma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Platelet and Plasma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Platelet
Plasma
Segment by Application
Hosptials
Clinics
Ambulatory Surgical Centres
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
America’s Blood Centers
American Red Cross
American Association of Blood Banks
Blood Centers of America
Brazilian Red Cross
Canadian Red Cross
European Blood Alliance
French Red Cross
German Red Cross
Blood Centers of America
Brazilian Red Cross
Red Cross Society of China
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Platelet and Plasma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Platelet
1.2.3 Plasma
1.3 Market by Application
1.3.1 Global Platelet and Plasma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hosptials
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Platelet and Plasma Market Perspective (2016-2027)
2.2 Platelet and Plasma Growth Trends by Regions
2.2.1 Platelet and Plasma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Platelet and Plasma Historic Market Share by Regions (2016-2021)
2.2.3 Platelet and Plasma Forecasted Market Size by Regions (2022-2027)
2.3 Platelet and Plasma Industry Dynamic
2.3.1 Platelet and Plasma Market Trends
2.3.2 Platelet and Plasma Market Drivers
2.3.3 Platelet and Plasma Market Challenges
2.3.4 Platelet and Plasma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Platelet and Plasma Players by Revenue
3.1.1 Global Top Platelet and Plasma Players by Revenue (2016-2021)
3.1.2 Global Platelet and Plasma Revenue Market Share by Players (2016-2021)
3.2 Global Platelet and Plasma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Platelet and Plasma Revenue
3.4 Global Platelet and Plasma Market Concentration Ratio
3.4.1 Global Platelet and Plasma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platelet and Plasma Revenue in 2020
3.5 Platelet and Plasma Key Players Head office and Area Served
3.6 Key Players Platelet and Plasma Product Solution and Service
3.7 Date of Enter into Platelet and Plasma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Platelet and Plasma Breakdown Data by Type
4.1 Global Platelet and Plasma Historic Market Size by Type (2016-2021)
4.2 Global Platelet and Plasma Forecasted Market Size by Type (2022-2027)
5 Platelet and Plasma Breakdown Data by Application
5.1 Global Platelet and Plasma Historic Market Size by Application (2016-2021)
5.2 Global Platelet and Plasma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Platelet and Plasma Market Size (2016-2027)
6.2 North America Platelet and Plasma Market Size by Type
6.2.1 North America Platelet and Plasma Market Size by Type (2016-2021)
6.2.2 North America Platelet and Plasma Market Size by Type (2022-2027)
6.2.3 North America Platelet and Plasma Market Size by Type (2016-2027)
6.3 North America Platelet and Plasma Market Size by Application
6.3.1 North America Platelet and Plasma Market Size by Application (2016-2021)
6.3.2 North America Platelet and Plasma Market Size by Application (2022-2027)
6.3.3 North America Platelet and Plasma Market Size by Application (2016-2027)
6.4 North America Platelet and Plasma Market Size by Country
6.4.1 North America Platelet and Plasma Market Size by Country (2016-2021)
6.4.2 North America Platelet and Plasma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Platelet and Plasma Market Size (2016-2027)
7.2 Europe Platelet and Plasma Market Size by Type
7.2.1 Europe Platelet and Plasma Market Size by Type (2016-2021)
7.2.2 Europe Platelet and Plasma Market Size by Type (2022-2027)
7.2.3 Europe Platelet and Plasma Market Size by Type (2016-2027)
7.3 Europe Platelet and Plasma Market Size by Application
7.3.1 Europe Platelet and Plasma Market Size by Application (2016-2021)
7.3.2 Europe Platelet and Plasma Market Size by Application (2022-2027)
7.3.3 Europe Platelet and Plasma Market Size by Application (2016-2027)
7.4 Europe Platelet and Plasma Market Size by Country
7.4.1 Europe Platelet and Plasma Market Size by Country (2016-2021)
7.4.2 Europe Platelet and Plasma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Platelet and Plasma Market Size (2016-2027)
8.2 Asia-Pacific Platelet and Plasma Market Size by Type
8.2.1 Asia-Pacific Platelet and Plasma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Platelet and Plasma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Platelet and Plasma Market Size by Type (2016-2027)
8.3 Asia-Pacific Platelet and Plasma Market Size by Application
8.3.1 Asia-Pacific Platelet and Plasma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Platelet and Plasma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Platelet and Plasma Market Size by Application (2016-2027)
8.4 Asia-Pacific Platelet and Plasma Market Size by Region
8.4.1 Asia-Pacific Platelet and Plasma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Platelet and Plasma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Platelet and Plasma Market Size (2016-2027)
9.2 Latin America Platelet and Plasma Market Size by Type
9.2.1 Latin America Platelet and Plasma Market Size by Type (2016-2021)
9.2.2 Latin America Platelet and Plasma Market Size by Type (2022-2027)
9.2.3 Latin America Platelet and Plasma Market Size by Type (2016-2027)
9.3 Latin America Platelet and Plasma Market Size by Application
9.3.1 Latin America Platelet and Plasma Market Size by Application (2016-2021)
9.3.2 Latin America Platelet and Plasma Market Size by Application (2022-2027)
9.3.3 Latin America Platelet and Plasma Market Size by Application (2016-2027)
9.4 Latin America Platelet and Plasma Market Size by Country
9.4.1 Latin America Platelet and Plasma Market Size by Country (2016-2021)
9.4.2 Latin America Platelet and Plasma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Platelet and Plasma Market Size (2016-2027)
10.2 Middle East & Africa Platelet and Plasma Market Size by Type
10.2.1 Middle East & Africa Platelet and Plasma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Platelet and Plasma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Platelet and Plasma Market Size by Type (2016-2027)
10.3 Middle East & Africa Platelet and Plasma Market Size by Application
10.3.1 Middle East & Africa Platelet and Plasma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Platelet and Plasma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Platelet and Plasma Market Size by Application (2016-2027)
10.4 Middle East & Africa Platelet and Plasma Market Size by Country
10.4.1 Middle East & Africa Platelet and Plasma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Platelet and Plasma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 America’s Blood Centers
11.1.1 America’s Blood Centers Company Details
11.1.2 America’s Blood Centers Business Overview
11.1.3 America’s Blood Centers Platelet and Plasma Introduction
11.1.4 America’s Blood Centers Revenue in Platelet and Plasma Business (2016-2021)
11.1.5 America’s Blood Centers Recent Development
11.2 American Red Cross
11.2.1 American Red Cross Company Details
11.2.2 American Red Cross Business Overview
11.2.3 American Red Cross Platelet and Plasma Introduction
11.2.4 American Red Cross Revenue in Platelet and Plasma Business (2016-2021)
11.2.5 American Red Cross Recent Development
11.3 American Association of Blood Banks
11.3.1 American Association of Blood Banks Company Details
11.3.2 American Association of Blood Banks Business Overview
11.3.3 American Association of Blood Banks Platelet and Plasma Introduction
11.3.4 American Association of Blood Banks Revenue in Platelet and Plasma Business (2016-2021)
11.3.5 American Association of Blood Banks Recent Development
11.4 Blood Centers of America
11.4.1 Blood Centers of America Company Details
11.4.2 Blood Centers of America Business Overview
11.4.3 Blood Centers of America Platelet and Plasma Introduction
11.4.4 Blood Centers of America Revenue in Platelet and Plasma Business (2016-2021)
11.4.5 Blood Centers of America Recent Development
11.5 Brazilian Red Cross
11.5.1 Brazilian Red Cross Company Details
11.5.2 Brazilian Red Cross Business Overview
11.5.3 Brazilian Red Cross Platelet and Plasma Introduction
11.5.4 Brazilian Red Cross Revenue in Platelet and Plasma Business (2016-2021)
11.5.5 Brazilian Red Cross Recent Development
11.6 Canadian Red Cross
11.6.1 Canadian Red Cross Company Details
11.6.2 Canadian Red Cross Business Overview
11.6.3 Canadian Red Cross Platelet and Plasma Introduction
11.6.4 Canadian Red Cross Revenue in Platelet and Plasma Business (2016-2021)
11.6.5 Canadian Red Cross Recent Development
11.7 European Blood Alliance
11.7.1 European Blood Alliance Company Details
11.7.2 European Blood Alliance Business Overview
11.7.3 European Blood Alliance Platelet and Plasma Introduction
11.7.4 European Blood Alliance Revenue in Platelet and Plasma Business (2016-2021)
11.7.5 European Blood Alliance Recent Development
11.8 French Red Cross
11.8.1 French Red Cross Company Details
11.8.2 French Red Cross Business Overview
11.8.3 French Red Cross Platelet and Plasma Introduction
11.8.4 French Red Cross Revenue in Platelet and Plasma Business (2016-2021)
11.8.5 French Red Cross Recent Development
11.9 German Red Cross
11.9.1 German Red Cross Company Details
11.9.2 German Red Cross Business Overview
11.9.3 German Red Cross Platelet and Plasma Introduction
11.9.4 German Red Cross Revenue in Platelet and Plasma Business (2016-2021)
11.9.5 German Red Cross Recent Development
11.10 Indian Red Cross
11.10.1 Indian Red Cross Company Details
11.10.2 Indian Red Cross Business Overview
11.10.3 Indian Red Cross Platelet and Plasma Introduction
11.10.4 Indian Red Cross Revenue in Platelet and Plasma Business (2016-2021)
11.10.5 Indian Red Cross Recent Development
11.11 Italian Red Cross
11.11.1 Italian Red Cross Company Details
11.11.2 Italian Red Cross Business Overview
11.11.3 Italian Red Cross Platelet and Plasma Introduction
11.11.4 Italian Red Cross Revenue in Platelet and Plasma Business (2016-2021)
11.11.5 Italian Red Cross Recent Development
11.12 Red Cross Society of China
11.12.1 Red Cross Society of China Company Details
11.12.2 Red Cross Society of China Business Overview
11.12.3 Red Cross Society of China Platelet and Plasma Introduction
11.12.4 Red Cross Society of China Revenue in Platelet and Plasma Business (2016-2021)
11.12.5 Red Cross Society of China Recent Development
11.13 Saudi Red Crescent Authority
11.13.1 Saudi Red Crescent Authority Company Details
11.13.2 Saudi Red Crescent Authority Business Overview
11.13.3 Saudi Red Crescent Authority Platelet and Plasma Introduction
11.13.4 Saudi Red Crescent Authority Revenue in Platelet and Plasma Business (2016-2021)
11.13.5 Saudi Red Crescent Authority Recent Development
11.14 South African Red Cross Society
11.14.1 South African Red Cross Society Company Details
11.14.2 South African Red Cross Society Business Overview
11.14.3 South African Red Cross Society Platelet and Plasma Introduction
11.14.4 South African Red Cross Society Revenue in Platelet and Plasma Business (2016-2021)
11.14.5 South African Red Cross Society Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Platelet and Plasma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Platelet
Table 3. Key Players of Plasma
Table 4. Global Platelet and Plasma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Platelet and Plasma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Platelet and Plasma Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Platelet and Plasma Market Share by Regions (2016-2021)
Table 8. Global Platelet and Plasma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Platelet and Plasma Market Share by Regions (2022-2027)
Table 10. Platelet and Plasma Market Trends
Table 11. Platelet and Plasma Market Drivers
Table 12. Platelet and Plasma Market Challenges
Table 13. Platelet and Plasma Market Restraints
Table 14. Global Platelet and Plasma Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Platelet and Plasma Market Share by Players (2016-2021)
Table 16. Global Top Platelet and Plasma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platelet and Plasma as of 2020)
Table 17. Ranking of Global Top Platelet and Plasma Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Platelet and Plasma Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Platelet and Plasma Product Solution and Service
Table 21. Date of Enter into Platelet and Plasma Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Platelet and Plasma Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Platelet and Plasma Revenue Market Share by Type (2016-2021)
Table 25. Global Platelet and Plasma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Platelet and Plasma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Platelet and Plasma Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Platelet and Plasma Revenue Market Share by Application (2016-2021)
Table 29. Global Platelet and Plasma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Platelet and Plasma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Platelet and Plasma Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Platelet and Plasma Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Platelet and Plasma Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Platelet and Plasma Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Platelet and Plasma Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Platelet and Plasma Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Platelet and Plasma Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Platelet and Plasma Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Platelet and Plasma Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Platelet and Plasma Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Platelet and Plasma Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Platelet and Plasma Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Platelet and Plasma Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Platelet and Plasma Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Platelet and Plasma Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Platelet and Plasma Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Platelet and Plasma Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Platelet and Plasma Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Platelet and Plasma Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Platelet and Plasma Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Platelet and Plasma Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Platelet and Plasma Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Platelet and Plasma Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Platelet and Plasma Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Platelet and Plasma Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Platelet and Plasma Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Platelet and Plasma Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Platelet and Plasma Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Platelet and Plasma Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Platelet and Plasma Market Size by Country (2022-2027) & (US$ Million)
Table 61. America’s Blood Centers Company Details
Table 62. America’s Blood Centers Business Overview
Table 63. America’s Blood Centers Platelet and Plasma Product
Table 64. America’s Blood Centers Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 65. America’s Blood Centers Recent Development
Table 66. American Red Cross Company Details
Table 67. American Red Cross Business Overview
Table 68. American Red Cross Platelet and Plasma Product
Table 69. American Red Cross Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 70. American Red Cross Recent Development
Table 71. American Association of Blood Banks Company Details
Table 72. American Association of Blood Banks Business Overview
Table 73. American Association of Blood Banks Platelet and Plasma Product
Table 74. American Association of Blood Banks Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 75. American Association of Blood Banks Recent Development
Table 76. Blood Centers of America Company Details
Table 77. Blood Centers of America Business Overview
Table 78. Blood Centers of America Platelet and Plasma Product
Table 79. Blood Centers of America Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 80. Blood Centers of America Recent Development
Table 81. Brazilian Red Cross Company Details
Table 82. Brazilian Red Cross Business Overview
Table 83. Brazilian Red Cross Platelet and Plasma Product
Table 84. Brazilian Red Cross Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 85. Brazilian Red Cross Recent Development
Table 86. Canadian Red Cross Company Details
Table 87. Canadian Red Cross Business Overview
Table 88. Canadian Red Cross Platelet and Plasma Product
Table 89. Canadian Red Cross Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 90. Canadian Red Cross Recent Development
Table 91. European Blood Alliance Company Details
Table 92. European Blood Alliance Business Overview
Table 93. European Blood Alliance Platelet and Plasma Product
Table 94. European Blood Alliance Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 95. European Blood Alliance Recent Development
Table 96. French Red Cross Company Details
Table 97. French Red Cross Business Overview
Table 98. French Red Cross Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 99. French Red Cross Recent Development
Table 100. German Red Cross Company Details
Table 101. German Red Cross Business Overview
Table 102. German Red Cross Platelet and Plasma Product
Table 103. German Red Cross Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 104. German Red Cross Recent Development
Table 105. Indian Red Cross Company Details
Table 106. Indian Red Cross Business Overview
Table 107. Indian Red Cross Platelet and Plasma Product
Table 108. Indian Red Cross Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 109. Indian Red Cross Recent Development
Table 110. Italian Red Cross Company Details
Table 111. Italian Red Cross Business Overview
Table 112. Italian Red Cross Platelet and Plasma Product
Table 113. Italian Red Cross Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 114. Italian Red Cross Recent Development
Table 115. Red Cross Society of China Company Details
Table 116. Red Cross Society of China Business Overview
Table 117. Red Cross Society of China Platelet and Plasma Product
Table 118. Red Cross Society of China Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 119. Red Cross Society of China Recent Development
Table 120. Saudi Red Crescent Authority Company Details
Table 121. Saudi Red Crescent Authority Business Overview
Table 122. Saudi Red Crescent Authority Platelet and Plasma Product
Table 123. Saudi Red Crescent Authority Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 124. Saudi Red Crescent Authority Recent Development
Table 125. South African Red Cross Society Company Details
Table 126. South African Red Cross Society Business Overview
Table 127. South African Red Cross Society Platelet and Plasma Product
Table 128. South African Red Cross Society Revenue in Platelet and Plasma Business (2016-2021) & (US$ Million)
Table 129. South African Red Cross Society Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Platelet and Plasma Market Share by Type: 2020 VS 2027
Figure 2. Platelet Features
Figure 3. Plasma Features
Figure 4. Global Platelet and Plasma Market Share by Application: 2020 VS 2027
Figure 5. Hosptials Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centres Case Studies
Figure 8. Others Case Studies
Figure 9. Platelet and Plasma Report Years Considered
Figure 10. Global Platelet and Plasma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Platelet and Plasma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Platelet and Plasma Market Share by Regions: 2020 VS 2027
Figure 13. Global Platelet and Plasma Market Share by Regions (2022-2027)
Figure 14. Global Platelet and Plasma Market Share by Players in 2020
Figure 15. Global Top Platelet and Plasma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platelet and Plasma as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Platelet and Plasma Revenue in 2020
Figure 17. Global Platelet and Plasma Revenue Market Share by Type (2016-2021)
Figure 18. Global Platelet and Plasma Revenue Market Share by Type (2022-2027)
Figure 19. North America Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Platelet and Plasma Market Share by Type (2016-2027)
Figure 21. North America Platelet and Plasma Market Share by Application (2016-2027)
Figure 22. North America Platelet and Plasma Market Share by Country (2016-2027)
Figure 23. United States Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Platelet and Plasma Market Share by Type (2016-2027)
Figure 27. Europe Platelet and Plasma Market Share by Application (2016-2027)
Figure 28. Europe Platelet and Plasma Market Share by Country (2016-2027)
Figure 29. Germany Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Platelet and Plasma Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Platelet and Plasma Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Platelet and Plasma Market Share by Region (2016-2027)
Figure 39. China Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Platelet and Plasma Market Share by Type (2016-2027)
Figure 47. Latin America Platelet and Plasma Market Share by Application (2016-2027)
Figure 48. Latin America Platelet and Plasma Market Share by Country (2016-2027)
Figure 49. Mexico Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Platelet and Plasma Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Platelet and Plasma Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Platelet and Plasma Market Share by Country (2016-2027)
Figure 55. Turkey Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Platelet and Plasma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. America’s Blood Centers Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 59. American Red Cross Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 60. American Association of Blood Banks Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 61. Blood Centers of America Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 62. Brazilian Red Cross Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 63. Canadian Red Cross Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 64. European Blood Alliance Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 65. French Red Cross Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 66. German Red Cross Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 67. Indian Red Cross Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 68. Italian Red Cross Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 69. Red Cross Society of China Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 70. Saudi Red Crescent Authority Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 71. South African Red Cross Society Revenue Growth Rate in Platelet and Plasma Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の血小板＆血漿市場規模・現状・予測（2021年-2027年） Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cell…- 世界の血漿分画市場規模・現状・予測（2021年-2027年） Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation. Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the…
- 世界の血漿プロテアーゼC1阻害剤治療市場規模・現状・予測（2021年-2027年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
- 世界の形質細胞新生物治療市場規模・現状・予測（2021年-2027年） Plasma cell neoplasms are diseases in which the body makes too many plasma cells. The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken…
- 世界の治療用血漿交換市場規模・現状・予測（2021年-2027年） Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely…